SUBSCRIBE
SUBSCRIBE
News   Drug Development

Neurosearch A/S Shares Fall; Drug Trials Stopped

October 19, 2005 | 
1 min read
COPENHAGEN -(Dow Jones)- Shares in NeuroSearch A/S (NEUR.KO), one of Denmark's pioneer biotech companies, plummeted 46% Wednesday as a partner declined to proceed with trials of one of the company's most promising drugs.
Clinical research Phase 3
Boehringer Ingelheim
MORE ON THIS TOPIC
The intertwining wires flash in different colors, 3D rendering illustration.
IPO
Electra lights up with $350M IPO for pivotal immune-disease drug development
September 18, 2026
 · 
1 min read
 · 
Gabrielle Masson
Psychological help and psycho therapy for mental health vector illustration. Two human heads silhouette paper cut design
Neuropsychiatric disorders
Xenon tumbles on voluntary psychiatry hold, but analysts confident in $2B epilepsy opportunity
September 18, 2026
 · 
4 min read
 · 
Annalee Armstrong
Sorting garbage concept. Cropped photo of paper thash. Crumple paper falling to the recycling bin
Cancer
BMS scraps Orum’s targeted degrader after reviewing Phase 1 data
September 18, 2026
 · 
1 min read
 · 
Tristan Manalac
Bridging the gap connect the path to success together, teamwork or partnership, collaboration or cooperation for winning challenge, businessman connect jigsaw puzzle as the bridge to connect the gap.
Deals
Novo notches up to $1.4B pact with Orbis to develop oral macrocycle cardiometabolic drugs
September 17, 2026
 · 
2 min read
 · 
Michael Gibney